NRx Pharmaceuticals, Inc. (NRXP) investor relations documents from the company's IR site: 3 presentations, 1 press release; latest deck 2025-12-09. Read in-app with summaries. First-party data.
Dr. Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals presents at NobleCon21 ̵: NRx Pharmaceuticals Founder and Chief Scientist Dr. Jonathan Javitt presented the company's clinical pipeline at the NobleCon21 Emerging Growth Equity Conference.
| Published | Type | Document |
|---|---|---|
| 2025-12-09 | Investor meeting | Dr. Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals presents at NobleCon21 ̵ |
| 2025-10-09 | Investor meeting | Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals, presents at Noble Capital Marke |
| 2025-04-07 | Press release | NRX-100’s Breakthrough in Suicidality Treatment |
| 2022-04-14 | Presentation | NRx Pharmaceuticals’ Interim CEO Presentation at 21st Annual Needham Virtual Healthcare Conference |
NRXP overview · NRXP earnings · NRXP financials · NRXP KPIs · NRXP ownership · NRXP peers · NRXP filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.